HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Nippon Kayaku Co., Ltd. - Financial and Strategic Analysis Review.
-
M2 Presswire; May 6, 2009; 700+ Words
...Analysis Review Nippon Kayaku Co., Ltd. - Financial and Strategic Analysis Review Summary Nippon Kayaku Co., Ltd. (Nippon) is a Japan based diversified manufacturing company. The company operates in four...
-
-
Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes.
-
PR Newswire; Jul 17, 2008; 700+ Words
...New York, NY) and Nippon Kayaku Co., Ltd. (Tokyo, Japan...a new joint venture company, GlycoMark, Inc...Tsusho America, Inc., Nippon Kayaku Co., Ltd., and the BioMarker...consumer sectors. About Nippon Kayaku Co., Ltd...
-
-
Nippon Kayaku Co., Ltd.-Company Report.
-
M2 Presswire; Feb 8, 2009; 653 Words
...Nippon Kayaku Co., Ltd.-Company Report...M2 COMMUNICATIONS LTD RDATE:08022009...adds new report: Nippon Kayaku Co., Ltd.-Company Report Private Company Reports provide up...biotechnology and biomedical companies. Scope of the report...
-
-
Having acquired 100% of its Japanese joint venture with Nippon Kayaku Co., Ltd. (Tokyo), named Kayaku Sartomer Co., Ltd., Exton, Pa.-based Sartomer Company announces that it will now operate in Japan on an independent basis.(Expansion)(Brief Article)
-
Plastics Engineering; Sep 1, 2004; ; 700+ Words
Having acquired 100% of its Japanese joint venture with Nippon Kayaku Co., Ltd. (Tokyo), named Kayaku Sartomer Co., Ltd., Exton, Pa.-based Sartomer Company announces that it will now operate in Japan on an independent basis...
-
-
Nippon Kayaku licenses Japanese ozarelix rights.(Spectrum Pharmaceuticals Licensing agreements with Nippon Kayaku Company Ltd)(Brief article)
-
Pharma Marketletter; Aug 14, 2006; 642 Words
...hormone-releasing hormone antagonist, ozarelix, has entered a licensing agreement with Japan's Nippon Kayaku. Under the terms of the deal, Kayaku has exclusive rights to develop and market the agent for all potential oncological indications...
-
-
Shionogi and Nippon Kayaku to develop AEterna's cetrorelix for benign prostate hyperplasia.(Aeterna Laboratories Inc., Shionogi and Company Ltd., Nippon Kayaku Company Ltd.)(Brief Article)
-
Pharma Marketletter; Mar 21, 2005; 700+ Words
Canadian drugmaker AEterna Zentaris has reported the decision of its Japanese partners Shionogi and Nippon Kayaku to progress the development of cetrorelix, a luteinizing hormone-releasing hormone antagonist, for the treatment of benign...
-
-
Other News To Note.(Carna Biosciences Inc. signs distribution deal with Bio-Connect BV and KinaseDetect ApS)(Neose Technologies Inc. and Novo Nordisk A/S enter into licensing agreement)(AEterna Zentaris Inc. and in a Nippon Kayaku Co. Ltd.)
-
BIOWORLD Today; Aug 7, 2006; 700+ Words
...Factors VIII and IX. The company also is working with Novo...Ranbaxy Laboratories Ltd., received tentative...Rosemont Pharmaceuticals Ltd., to an entity affiliated...collaboration agreement with Nippon Kayaku Co. Ltd., of Tokyo, for the...
-
-
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market.
-
Business Wire; Apr 16, 2009; 700+ Words
...NASDAQ: BSMD) - a medical device company that has pioneered the use of...signed an exclusive agreement with Nippon Kayaku Co., Ltd. for the planned distribution...According to the agreed-upon terms, Nippon Kayaku will be responsible for regulatory...
-
-
Unidym Inks Development Deal with Nippon Kayaku
-
Wireless News; Mar 17, 2008; 425 Words
...cells. Nippon Kayaku is a diversified Japanese chemical company that is bringing...and consulting company, thin-film photovoltaic...innovative solar companies like Nippon Kayaku and accelerate...Communications Ltd - http://www...
-
-
NeoPharm Announces Japanese Licensing Agreement for IL13-PE38QQR with Nippon Kayaku.
-
Business Wire; Jan 4, 2005; 700+ Words
...NEOL) today announced that Nippon Kayaku Co., Ltd. has signed an exclusive license...front license fee of $2 million. Nippon Kayaku is responsible for all development...Executive Officer. "We had a company goal of increasing our licensing...
-
-
Axiom, Zaiya And Nippon Kayaku Enter Anti-Cancer Drug Discovery Research Collaboration.
-
Business Wire; Nov 19, 1997; 700+ Words
...will be coupled to the company's High Throughput...in this program." Nippon Kayaku Co. Ltd. is a leading Japanese...chemical products. Nippon Kayaku is specialized in oncology...one of the leading companies in the field in Japan...
-
-
United Kingdom: Unidym Enters into Development Agreement with Nippon Kayaku.
-
TendersInfo; Mar 20, 2008; 700+ Words
...economics for innovative solar companies like Nippon Kayaku and accelerate widespread adoption of solar power. Nippon Kayaku is delighted to be working...Euclid Infotech Pvt. Ltd. Provided by Syndigate.info an Albawaba.com company
-
-
JAPAN'S NIPPON KAYAKU STRENGTHENING EFFORTS TO SELL CANCER DRUGS.
-
AsiaPulse News; Sep 11, 2003; 440 Words
...selling cancer drugs. The company has seen little sales...the chemical division. Nippon Kayaku recently began sales of...version of a Merck Hoei Ltd. cancer treatment and...France. In fiscal 2002, Nippon Kayaku's pharmaceutical sales...
-
-
Nippon Kayaku, Shionogi Release Cetrotide, Premature Ovulation Inhibitor, in Japan
-
JCNN News Summaries - Japan Corporate News Network; Sep 21, 2006; ; 327 Words
...2006 - (JCN) - Shionogi and Nippon Kayaku announced on September 21 the...injection. Canadian biopharmaceutical company AEterna Zentaris, through German...in Japan on April 20, 2006. Nippon Kayaku Co., Ltd. will import from Zentaris and...
-
-
Kayaku Akzo Co. acquires Sanken's organic peroxide business in Japan.
-
Business Wire; Jul 23, 1997; 700+ Words
...July 23, 1997--Kayaku Akzo Co. (KAC...between Akzo Nobel and Nippon Kayaku Co., has acquired...Sanken Chemical Corp. Ltd. The acquisition...technology-based company, serving customers...and fibers. The company employs 70,000...
-
-
Spectrum Enters $151M Cancer Drug Collaboration with Nippon.
-
BIOWORLD Today; Nov 11, 2009; 700+ Words
...Spectrum Pharmaceuticals Inc. and Nippon Kayaku Co. Ltd. have signed an exclusive collaboration...million for Spectrum. Tokyo-based Nippon Kayaku will make a $15 million up...141 million in cash, which the company estimates could last about two...
-
-
AEterna Zentaris Launches Cetrotide(R) (cetrorelix) in Japan for In Vitro Fertilization.
-
PR Newswire; Sep 21, 2006; 700+ Words
...Japan by partners Nippon Kayaku Co., Ltd. and Shionogi & Co., Ltd. AEterna Zentaris...achievement for our Company as Cetrotide...partners such as Nippon Kayaku and Shionogi will...and marketed by Nippon Kayaku and Shionogi...
-
-
AEterna Zentaris Gains Market Approval for Cetrotide(R) (cetrorelix) in Japan for In Vitro Fertilization.
-
PR Newswire; Apr 20, 2006; 700+ Words
...Japan by partners Nippon Kayaku Co., Ltd. and Shionogi & Co., Ltd. AEterna Zentaris obtained...highly respected partners as Nippon Kayaku and Shionogi to ensure the...substance was developed by the Company in cooperation with Nobel...
-
-
FDA Clears GlycoMark(TM) Test for People With Diabetes; GlycoMark(TM) Monitors Intermediate Glycemic Control.
-
PR Newswire; Nov 6, 2003; 700+ Words
...Tomen America Inc. and Nippon Kayaku Co. Ltd. today announced that the U...milestone for Tomen America and Nippon Kayaku. There is significant market...an initial breakthrough. The company has since developed a powerful...
-
-
BioSphere Medical Second Quarter Loss Narrows Significantly on 14% Growth in U.S. Embolics and Delivery Systems Revenue.(Financial report)
-
Business Wire; Jul 29, 2009; 700+ Words
...BSMD) ("BioSphere" or the "Company") - a medical device company...was signed in April 2009 with Nippon Kayaku Co., Ltd. for the distribution of HepaSphere...into an exclusive agreement with Nippon Kayaku for the distribution of HepaSphere...
|
|